Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jun 14, 2023

BUY
$8.51 - $13.6 $17,428 - $27,852
2,048 New
2,048 $21.5 Million
Q2 2022

Jun 20, 2023

BUY
$7.31 - $11.85 $14,970 - $24,268
2,048 New
2,048 $19,000
Q2 2022

Mar 30, 2023

SELL
$7.31 - $11.85 $50,599 - $82,025
-6,922 Reduced 77.17%
2,048 $19,000
Q2 2022

Aug 11, 2022

BUY
$7.31 - $11.85 $14,970 - $24,268
2,048 New
2,048 $20,000
Q4 2020

Feb 16, 2021

SELL
$4.37 - $9.46 $39,198 - $84,856
-8,970 Closed
0 $0
Q3 2020

Jun 26, 2023

BUY
$8.56 - $26.93 $76,783 - $241,562
8,970 New
8,970 $81,000
Q2 2020

Jun 26, 2023

BUY
$21.21 - $31.55 $190,253 - $283,003
8,970 New
8,970 $246,000
Q2 2020

Mar 30, 2023

BUY
$21.21 - $31.55 $32,811 - $48,807
1,547 Added 20.84%
8,970 $246,000
Q2 2020

Aug 14, 2020

BUY
$21.21 - $31.55 $32,811 - $48,807
1,547 Added 20.84%
8,970 $246,000
Q1 2020

Jul 12, 2023

BUY
$18.43 - $38.04 $136,805 - $282,370
7,423 New
7,423 $163,000
Q4 2019

Jul 12, 2023

BUY
$29.6 - $43.71 $219,720 - $324,459
7,423 New
7,423 $280,000
Q3 2019

Jul 12, 2023

BUY
$29.87 - $42.22 $221,725 - $313,399
7,423 New
7,423 $229,000
Q3 2019

Mar 30, 2023

BUY
$29.87 - $42.22 $44,117 - $62,358
1,477 Added 24.84%
7,423 $229,000
Q3 2019

Nov 14, 2019

BUY
$29.87 - $42.22 $44,117 - $62,358
1,477 Added 24.84%
7,423 $229,000
Q2 2019

Jul 12, 2023

BUY
$31.16 - $39.46 $195,155 - $247,137
6,263 New
6,263 $247,000
Q1 2019

Jul 13, 2023

BUY
$19.96 - $38.62 $118,682 - $229,634
5,946 New
5,946 $229,000
Q1 2019

Mar 30, 2023

BUY
$19.96 - $38.62 $118,682 - $229,634
5,946 New
5,946 $229,000
Q1 2019

May 16, 2019

SELL
$19.96 - $38.62 $62,474 - $120,880
-3,130 Reduced 34.49%
5,946 $229,000
Q1 2019

May 15, 2019

BUY
$19.96 - $38.62 $62,474 - $120,880
3,130 Added 52.64%
9,076 $669,000
Q4 2018

Jul 13, 2023

BUY
$23.57 - $32.33 $140,147 - $192,234
5,946 New
5,946 $140,000
Q4 2018

Feb 14, 2019

BUY
$23.57 - $32.33 $109,459 - $150,140
4,644 Added 356.68%
5,946 $140,000
Q3 2018

Jul 13, 2023

BUY
$22.5 - $39.35 $133,785 - $233,975
5,946 New
5,946 $182 Million
Q3 2018

Nov 14, 2018

BUY
$22.5 - $39.35 $29,295 - $51,233
1,302 New
1,302 $40,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.